ACGL vs CME
Arch Capital Group vs CME Group — AI-powered side-by-side comparison
ACGL
Arch Capital Group
69
Buy
VS
| Metric | ACGL | CME |
|---|
| AI Score |
69
|
63
|
| Price |
$100.70
|
$281.06
|
| P/E Ratio |
7.76×
|
23.40×
|
| ROE |
18.2%
|
14.1%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
46.2%
|
81.9%
|
| Debt / Equity |
0.18×
|
0.13×
|
| Dividend Yield |
0.0%
|
4.1%
|
| RSI (14) |
60.2
|
68.7
|
| Beta |
0.288
|
0.267
|
| Expected Upside |
+2.7%
|
+3.7%
|
AI Committee View
Current Innellis committee reasoning for ACGL versus CME.
ACGL leads by 6 points.
ACGL scores 69/100 (Buy) versus CME at 63/100 (Buy).
ACGL Committee View
100% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.11) -- balance sheet can absorb a shock. The main limiting factor is sector concentration is already high (hhi 3079.8). The committee is constructive but not yet at full conviction.
Bull Case
- P/E of 7.1 is inexpensive for the broad market — Value
- Price-to-book of 1.4x is a discount to asset value — Value
- ROE of 19.5% shows genuine earnings power backing the valuation — Value
Bear Case
- Revenue declining -0.8% YoY -- this is not a growth story right now — Growth
CME Committee View
67% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.12) -- balance sheet can absorb a shock. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 15.6% shows genuine earnings power backing the valuation — Value
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth